Antiserum previously preabsorbed on protein carriers and purified by ammonium sulfate precipitation.
This antibody targets conjugated 5-Hydroxytryptamine. This antibody does not recognize free 5-Hydroxytryptamine.
Using a conjugate 5-hydroxytryptamine-Glutaraldehyde-BSA, antibody specificity was performed with an ELISA test by competition experiments with the following compounds: 5-Hydroxytryptamine-G-BSA (1), 5-Methoxytryptamine-G-(Pc) (1/25), Tryptamine-G-(Pc) (1/50), 5-Hydroxytryptophan-G-(Pc) (1/175), 5-Hydroxytryptamine (1/1,150), Tryptophan-G-(Pc) (1/3,500), 5-Methoxytryptophan-G-(Pc) (1/20,000).
Tested applications include immunocytochemistry and immunohistochemistry.
To view protocol(s) for this and other products please visit: www.ATSbio.com/support/protocols
Advanced Targeting Systems(ATS)位于美国加州圣地亚哥, 成立于1994年。 公司发起人Douglas Lappi和Ronald Wiley博士在实验室开发出先进的分子神经外科学研究技术。ATS主要生产用于科研和药物研发的靶向试剂,公司在疼痛和药物转运的研究及临床治疗的两个产品已获专利保护。目前,产品包括靶向毒素 (可提供基底前脑胆碱能神经元、去甲肾上腺素能和肾上腺素能神经元、巨噬细胞和小胶质细胞的特异性损伤试剂等)、二抗生物素、神经元抗体、神经递质抗体、蛋白质和荧光结合物、免疫毒素对照等。